Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reuter

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Plos One|November 18, 2017
New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal studyD Wybrecht, F Reuter, F Pariollaud, et al.
Cancer|June 15, 1996
A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinomaT M Pisansky, C L Loprinzi, S S Cha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosumB Audoin, D Ibarrola, I Malikova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancerSumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
American Journal of Clinical Oncology|August 1, 1985
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureJ N Ingle, D M Pfeifle, S J Green, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Plos One|November 18, 2017
New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal studyD Wybrecht, F Reuter, F Pariollaud, et al.
Cancer|June 15, 1996
A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinomaT M Pisansky, C L Loprinzi, S S Cha, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosumB Audoin, D Ibarrola, I Malikova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancerSumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
American Journal of Clinical Oncology|August 1, 1985
Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureJ N Ingle, D M Pfeifle, S J Green, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG studyThanyanan Reungwetwattana, Julian R Molina, Sumithra J Mandrekar, et al.
Pageof 5